Expression of matrix metalloproteinase-9 (MMP-9) and blood vessel density in laryngeal squamous cell carcinomas

Acta Oto-Laryngologica

Volumn 131, Issue 1, 2010, Pages 101-106

  Wittekindt, Claus ^a   Jovanovic, Nebojsa ^b   Guntinas Lichius, Orlando ^c  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

immunohistochemistry; laryngeal cancer; Matrix metalloproteinases

Indexed keywords

GELATINASE B;

ADULT; AGED; ARTICLE; BLOOD VESSEL DENSITY; BLOOD VESSEL PARAMETERS; CANCER RECURRENCE; CANCER STAGING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNGEAL SQUAMOUS CELL CARCINOMA; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; BLOOD VESSELS; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; STATISTICS AS TOPIC;

EID: 78650272863     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.3109/00016489.2010.506886     Document Type: Article

References (20)

1. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2: 161-74.
2. Balbin M, Fueyo A, Tester AM, Pendas AM, Pitiot AS, Astudillo A, et al. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat Genet 2003;35: 252-7.
3. Handsley MM, Edwards DR. Metalloproteinases and their inhibitors in tumor angiogenesis. Int J Cancer 2005;115: 849-60.
4. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000;2:737-44.
5. Coussens LM, Tinkle CL, Hanahan D, Werb Z. MMP-9- supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000;103:481-90.
6. Zijlstra A, Seandel M, Kupriyanova TA, Partridge JJ, Madsen MA, Hahn-Dantona EA, et al. Proangiogenic role of neutrophil-like inflammatory heterophils during neovascularization induced by growth factors and human tumor cells. Blood 2006;107:317-27.
7. Chantrain CF, Shimada H, Jodele S, Groshen S, Ye W, Shalinsky DR, et al. Stromal matrix metalloproteinase-9- regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment. Cancer Res 2004;64:1675-86.
8. Hirota J, Yoneda K, Osaki T. Basement membrane type IV collagen in oral squamous cell carcinoma. Head Neck 1990; 12:400-5.
9. Jodele S, Blavier L, Yoon JM, DeClerck YA. Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression. Cancer Metastasis Rev 2006;25:35-43.
10. Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, et al. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 1990;348:699-704.
11. Zucker S, Vacirca J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 2004;23:101-17.
12. Sugiura Y, Shimada H, Seeger RC, Laug WE, DeClerck YA. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis. Cancer Res 1998;58: 2209-16.
13. Nielsen BS, Sehested M, Kjeldsen L, Borregaard N, Rygaard J, Dano K. Expression of matrix metalloprotease-9- in vascular pericytes in human breast cancer. Lab Invest 1997;77:345-55.
14. Coussens LM, Raymond WW, Bergers G, Laig-Webster M, Behrendtsen O, Werb Z, et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 1999;13:1382-97.
15. Sang QX. Complex role of matrix metalloproteinases in angiogenesis. Cell Res 1998;8:171-7.
16. O-Charoenrat P, Rhys-Evans PH, Eccles SA. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2001;127: 813-20.
17. Overall CM, Lopez-Otin C. Strategies forMMPinhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2002;2:657-72.
18. Fujino H, Kondo K, Ishikura H, Maki H, Kinoshita H, Miyoshi T, et al. Matrix metalloproteinase inhibitor MMI-166 inhibits lymphogenous metastasis in an orthotopically implanted model of lung cancer. Mol Cancer Ther 2005;4:1409-16.
19. Bergers G, Javaherian K, Lo KM, Folkman J, Hanahan D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 1999;284:808-12.
20. Kruger A, Soeltl R, Sopov I, Kopitz C, Arlt M, Magdolen V, et al. Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis. Cancer Res 2001;61:1272-5.